Document is current
Any future updates will be listed below
-
Authors
Li, Fenglin
Bellis, Nathan F.
Lokareddy, Ravi K. https://orcid.org/0000-0002-5357-1857
Hou, Chun-Feng David
Yang, Ruoyu
Branston, Steven
Kovach, Zsuzsanna
Geier, Renae
Soriaga, Angela
Sim, Lucy
Kyme, Pierre
Birx, Deborah
Lemire, Sebastien
Cingolani, Gino https://orcid.org/0000-0002-9206-9640
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM100888)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM100888)
- License Information
-
More Information
Article History
Received: 26 November 2025
Accepted: 20 April 2026
First Online: 30 April 2026
Competing interests
: Z.K., S.B., R.G., A.S., L.S., P.K., D.B., and S.L. are employees of Armata Pharmaceuticals Inc., a company involved in the development of bacteriophage therapies. The remaining authors declare no competing interests.
